EAACI London 2010

The treatment of allergic rhinitis and chronic urticaria has improved markedly over the past few years as a result of our better understanding of the mechanisms of allergic disease and the availability of effective treatments.

Bilastine is a new addition to the family of non-sedating H1 antihistamines. In this symposium, we have the privilege of presenting a renowned panel of experts to present the scientific and clinical evidence regarding the use of bilastine in the treatment of allergic rhinitis and chronic urticaria.

Only registered health professionals are allowed to see the report